Caisse invests $250mn in Avison Young

By zaymalz malz
Share

Canada’s second largest pension fund, Caisse de dépôt et placement du Québec (Caisse), has announced that it has invested $250mn in Toronto-based commercial real estate company Avison Young.

“With its unique corporate culture and its long-term vision, Avison Young is an ideal partner for Caisse, and we look forward to supporting the company as it continues to grow over the coming years,” said Stephane Etroy, Executive Vice-President and Head of Private Equity at Caisse.

See also:

Avison Young will use a portion of the latest funds to repurchase shares held by its private equity partner, Parallel49 Equity.

However, the majority of the investment will provide the firm with the necessary capital to continue to accelerate its global expansion plans, pursuing its own acquisitions, enhancing its recruitment procedures and bolstering its services.

“Caisse’s investment will provide additional momentum as we accelerate our innovative and technology-based capabilities and market presence to serve clients facing today’s rapidly changing real estate environment,” said Mark Rose, Chairman and CEO of Avison Young.

As a result of the investment, Caisse will be designated three positions on Avison Young’s Board of Directors that consists of nine members.

Share

Featured Articles

What is Nestlé CEO Laurent Freixe’s Action Plan?

Newly appointed CEO sets out action plan involving separating water brands into standalone business and boosting advertising and marketing spend

Will Mulberry Turn a New Leaf Under CEO Andrea Baldo?

International British luxury brand cuts quarter of head office staff as newly appointed CEO conducts strategic review

Female Board Members of Biggest UK Companies Paid 69% Less

Female board members of FTSE 100 companies are paid 69% less than male counterparts, as they find themselves frozen out of the biggest roles

Is This the Next CEO of LVMH?

Leadership & Strategy

How Burberry’s New CEO Is Going Back to Basics

Leadership & Strategy

Is Bayer CEO Bill Anderson Running Out of Time?

Leadership & Strategy